Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, United Kingdom.
J Biol Chem. 2010 Mar 19;285(12):8543-51. doi: 10.1074/jbc.M109.045906. Epub 2010 Jan 14.
Tumor cells release NKG2D ligands to evade NKG2D-mediated immune surveillance. The purpose of our investigation was to explore the cellular mechanisms of release used by various members of the ULBP family. Using biochemical and cellular approaches in both transfectant systems and tumor cell lines, this paper shows that ULBP1, ULBP2, and ULBP3 are released from cells with different kinetics and by distinct mechanisms. Whereas ULBP2 is mainly shed by metalloproteases, ULBP3 is abundantly released as part of membrane vesicles known as exosomes. Interestingly, exosomal ULBP3 protein is much more potent for down-modulation of the NKG2D receptor than soluble ULBP2 protein. This is the first report showing functionally relevant differences in the biochemistry of the three members of the ULBP family and confirms that in depth study of the biochemical features of individual NKG2D ligands will be necessary to understand and manipulate the biology of these proteins for therapy.
肿瘤细胞释放 NKG2D 配体以逃避 NKG2D 介导的免疫监视。我们研究的目的是探索 ULBP 家族各成员所使用的细胞释放机制。本文通过转染系统和肿瘤细胞系中的生化和细胞方法,表明 ULBP1、ULBP2 和 ULBP3 以不同的动力学和不同的机制从细胞中释放。虽然 ULBP2 主要通过金属蛋白酶脱落,但 ULBP3 作为称为外泌体的膜囊泡的一部分大量释放。有趣的是,外泌体 ULBP3 蛋白对 NKG2D 受体的下调作用比可溶性 ULBP2 蛋白强得多。这是首次报道 ULBP 家族的三个成员在生物化学方面存在功能相关的差异,并证实深入研究单个 NKG2D 配体的生化特征对于理解和操纵这些蛋白质的生物学特性以进行治疗是必要的。